Drug intelligence / Profile preview

iron polymaltose complex

Development stage
Unknown
Lead developer
Chemopharma
Modality
Small Molecules
Administration
Oral
01

Overview

Ferranem Microgránulos is an oral iron supplement containing iron(III) hydroxide polymaltose complex (IPC). Developed and marketed by the Chilean pharmaceutical company Chemopharma, it is indicated for the prevention and treatment of iron deficiency and iron deficiency anemia. The IPC formulation consists of a polynuclear iron(III)-hydroxide core surrounded by polymaltose molecules, which protects the iron from causing oxidative damage in the gastrointestinal tract and allows for controlled absorption via active transport. This results in improved tolerability and a lower incidence of gastrointestinal side effects compared to traditional ferrous salts. The microgranule formulation is specifically designed to provide flexible dosing and ease of administration for patients who may have difficulty with traditional tablet forms.

Brand names
Ferranem MicrogránulosFerranem
Other names
Iron(III) hydroxide polymaltose complexFerric polymaltose complexIPC

Beyond the preview

Go deeper on iron polymaltose complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iron polymaltose complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call